Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks
People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine because of the wider benefit to their families, friends and neighbours – as well as the direct benefit to themselves, a leading expert has said.
Prof David Spiegelhalter, the chair of the Winton Centre for Risk and Evidence Communication at the University of Cambridge, said the advantages of continuing to vaccinate people far outweighed the risks.
